Skip to content

Alpha Book

Actu

Fazekas Score 3: what impact on patients’ life expectancy?

A Fazekas score of 3 on the brain MRI indicates extensive lesions of the white matter, often described as severe. For patients who receive…

Neurologue senior analysant des IRM cérébraux montrant des lésions de la substance blanche liées au score de Fazekas 3

A Fazekas score of 3 on the brain MRI indicates extensive lesions in the white matter, often described as severe. For patients receiving this result, the question of life expectancy arises immediately. The answer depends on several parameters that the score alone does not capture: cardiovascular comorbidities, precise location of the lesions, rate of progression, and therapeutic management.

Fazekas Score: What Each Grade Indicates in Terms of Brain Lesions

The Fazekas classification remains the most commonly used tool in clinical practice to quantify white matter hyperintensities visible on MRI. It distinguishes three grades, each corresponding to an increasing degree of cerebral vascular damage.

Fazekas Grade Description of Lesions Common Clinical Interpretation
Grade 1 Punctate or linear lesions, isolated, less than 20 mm Common marker of normal aging, rarely symptomatic
Grade 2 Moderate lesions, confluent areas less than 20 mm Monitoring recommended, especially in the presence of vascular risk factors
Grade 3 Extensive confluent lesions, diffuse white matter damage Severe damage, associated with an increased risk of cognitive disorders and stroke

A Fazekas 3 does not mean that dementia is inevitable. It indicates that small vessel disease has reached an advanced stage, necessitating close neurological follow-up. To better understand the significance of Fazekas 3 on Pharmactuelle, this grade must be placed in the overall context of the patient’s vascular status.

Elderly patient in neurological consultation discussing MRI results and the Fazekas score and its impact on health

Fazekas 3 and Life Expectancy: Why the Grade Alone Is Not Enough

No published data allows for the establishment of a precise life expectancy based solely on the Fazekas 3 score. This grade describes the extent of lesions at a given moment, not their trajectory or functional consequences in a particular individual.

A systematic review published in Brain Imaging and Behavior emphasizes that a comprehensive assessment includes lacunes, micro-bleeds, perivascular spaces, and cerebral atrophy. Fazekas 3 is a piece of the puzzle, not the entire puzzle.

Factors That Modulate the Prognosis of a Fazekas 3

Two patients with an identical Fazekas 3 can have very different trajectories. The determining factors are:

  • Blood pressure control: untreated hypertension accelerates the progression of white matter lesions and cognitive decline, according to a research report published in 2024 linking increased blood pressure and increased lesion burden
  • The presence or absence of lacunes and micro-bleeds, which indicate deeper vascular damage than just hyperintensities
  • The location of the lesions: a meta-analysis of 36 prospective studies shows that associations with the risk of dementia vary by location (periventricular or deep subcortical)
  • Associated comorbidities (diabetes, atrial fibrillation, chronic kidney failure), which amplify the overall cardiovascular risk

Progression over time provides more reliable information than a single measurement. A stable Fazekas 3 over several years does not have the same significance as a Fazekas that has progressed from 1 to 3 in a short period.

Risks Associated with Fazekas 3: Cognitive Decline, Stroke, and Vascular Dementia

Confluent lesions in the white matter disrupt the transmission of signals between different regions of the brain. Three consequences dominate the medical literature.

The risk of cognitive disorders significantly increases at grade 3. Executive functions (planning, attention, mental flexibility) are the first to be affected, before memory itself. This distinction is useful: unlike Alzheimer’s disease, the cognitive profile of vascular leukoencephalopathy first manifests as a slowing of information processing.

The link with strokes is also documented. White matter lesions reflect fragility of small vessels that can promote both ischemic strokes and micro-bleeds.

Severe vascular leukoencephalopathy does not equate to dementia, but it notably increases the risk of dementia. However, a significant proportion of Fazekas 3 patients maintain preserved cognitive functions, especially when vascular risk factors are properly managed.

Close-up of brain MRIs placed on a lightbox showing hyperintensities of white matter characteristic of Fazekas score 3

Management of Fazekas 3: Slowing the Progression of Lesions

There is no curative treatment for already established lesions. Damaged white matter does not regenerate. The strategy relies on controlling risk factors to slow the appearance of new lesions.

Strict control of blood pressure is the main lever. It is the best-documented modifiable factor in the progression of small vessel disease. Antihypertensive treatments, tailored to each profile, aim to maintain blood pressure within recommended targets.

Other management axes include diabetes management, smoking cessation, treatment of any dyslipidemia, and maintaining regular physical activity. Follow-up with MRI allows for measuring the evolution of lesion burden and adjusting the therapeutic strategy.

Neuropsychological Follow-Up and Quality of Life

A regular neuropsychological assessment helps to detect early declines in executive functions. This early detection allows for adapting support (speech therapy, occupational therapy, daily adjustments) before the disorders affect the patient’s autonomy.

The quality of life of a Fazekas 3 patient depends as much on the management of comorbidities as on the MRI score itself. Rigorous vascular follow-up can favorably modify the clinical trajectory, even at the most advanced stage of the classification.

The Fazekas score of 3 indicates severe damage that justifies sustained medical vigilance. It does not, by itself, determine a vital prognosis. The progression of lesions, comorbidities, and the quality of blood pressure control weigh more heavily in the balance than the grade observed on a single MRI.

Fazekas Score 3: what impact on patients’ life expectancy?